Double distinction for BIOIATRIKI Healthcare Group at Cyprus Healthcare Business Awards

BIOIATRIKI Healthcare Group (Yiannoukas Medical Laboratories – Alpha Evresis Diagnostic Center) was awarded twice at the first Cyprus Healthcare Business Awards 2020· our Group was awarded with the silver prize in the section “Development and Innovation” and the bronze in the section “Quality of Services”. The aim of the event was to highlight and reward all those who, in 2020, a difficult year for the field of health, managed to stand out and excel in business and science.

After the announcement of the double award, the President & CEO of the BIOIATRIKI Healthcare Group, Mr. Georgios Spanos stated: “BIOIATRIKI Healthcare Group’s distinction in Cyprus among the leading players in the health sector, and in fact, in two of the most competitive categories, is a reward for our timeless commitment to excellence and the provision of high level of primary health services to everyone. At the same time, these awards seal our three-year successful presence throughout Cyprus, for our investment on digital transformation, the use of innovative tools and easily accessible services for all”.  BIOIATRIKI Healthcare Group has been active in Cyprus since 2017 when it became the majority shareholder of Yiannoukas Medical Laboratories and fully acquired the Alpha Evresis Diagnostic Center.

Additionally, the Group had undertaken the design, equipment, staffing and overall operation of the German Oncology Center’s clinical laboratory within its facilities. Since 2020, the first Polydynamo Center operates in Nicosia under the name of the Group, where the patients can do both their clinical and diagnostic examinations. Operating a total of 17 facilities throughout Cyprus, the Group currently carries out more than 3,500 clinical examinations, with international accreditations, and with the most modern radiodiagnostic medical devices, which include the use of artificial intelligence technology.